To include your compound in the COVID-19 Resource Center, submit it here.

TGEN starts Phase II trial

Targeted Genetics (TGEN) began a U.S. Phase II trial of

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE